AZITHROMYCIN

💡

Quick Summary

Azithromycin is a semi-synthetic macrolide antibiotic used to treat a wide variety of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted infections (STIs). It works by binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis and thereby stopping bacterial growth. Its primary clinical advantage is an exceptionally long tissue half-life, allowing for short, convenient dosing regimens (such as a 5-day course or single-dose therapy) and excellent intracellular penetration for atypical pathogens. The most important clinical consideration is the risk of QT interval prolongation, which requires caution in patients with existing cardiac arrhythmias or those taking other QT-prolonging medications.

🔬

Drug Identity

GENERIC NAMEAzithromycin
MEDOBO IDMDBD0033
ATC CODEJ01FA10
PHARMACOLOGICAL CLASSMacrolide Antibiotic (Azalide)
THERAPEUTIC CLASSAntibacterial
THERAPEUTIC CATEGORYInfectious Disease
CHEMICAL NAME(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
DRUG SOURCESemi-synthetic
FDA APPROVAL1991
MODALITYSmall Molecule
DRUG TYPEantibiotic
MARKET STATUS● Approved
CORE USE TAGS
AntibioticMacrolideRespiratory InfectionsSTIAtypical Pneumonia
BRAND NAMES (GLOBAL)
ZithromaxZmaxAzasiteSumamedAzeeAzimaxZithroxHemomycinAzithrocinAzithralXithroneZeto
SYNONYMS
Azithromycin dihydrate
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.
  • Community-acquired pneumonia (CAP) caused by Chlamydophila pneumoniae, Haemophilus influenzae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, or Streptococcus pneumoniae.
  • Acute bacterial sinusitis caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.
  • Pharyngitis and tonsillitis caused by Streptococcus pyogenes in patients who cannot use first-line therapy.
  • Uncomplicated skin and skin structure infections caused by Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiae.
  • Urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeae.
  • Genital ulcer disease in men due to Haemophilus ducreyi (chancroid).
🔬 OFF-LABEL USES
  • Pertussis (whooping cough) treatment and post-exposure prophylaxis — Centers for Disease Control and Prevention (CDC) recommended first-line.
  • Traveler's diarrhea — recommended by the Infectious Diseases Society of America (IDSA) for severe cases or Campylobacter infections.
  • Mycobacterium avium complex (MAC) prophylaxis and treatment in advanced human immunodeficiency virus (HIV) infection.
  • Cystic fibrosis chronic maintenance — utilized for immunomodulatory and anti-inflammatory properties.
  • Cholera — adjunct to rehydration to reduce duration and severity of diarrhea.
  • Rosacea (papulopustular and ocular) — for anti-inflammatory effects.
  • Typhoid fever — alternative agent in regions with high fluoroquinolone resistance.
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.